Thel, M. C., Davidson, C. J., Aguirre, F. V., Peck, S. L., Tcheng, J. E., Lincoff, A. M., … Califf, R. M. (1997). What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29(2), 8210–8210.

Thel, M. C., C. J. Davidson, F. V. Aguirre, S. L. Peck, J. E. Tcheng, A. M. Lincoff, E. J. Topol, and R. M. Califf. “What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 29, no. 2 (February 1, 1997): 8210–8210.

Thel MC, Davidson CJ, Aguirre FV, Peck SL, Tcheng JE, Lincoff AM, et al. What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 1997 Feb 1;29(2):8210–8210.

Thel, M. C., et al. “What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 29, no. 2, ELSEVIER SCIENCE INC, Feb. 1997, pp. 8210–8210.

Thel MC, Davidson CJ, Aguirre FV, Peck SL, Tcheng JE, Lincoff AM, Topol EJ, Califf RM. What predicts contrast nephropathy after coronary intervention? Insights from the IMPACT II trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 1997 Feb 1;29(2):8210–8210.